ESMO 2018: Axitinib for the treatment of metastatic papillary renal cell carcinoma in the first-line
The results from a phase 2 clinical trial to assess [...]
The results from a phase 2 clinical trial to assess [...]
A retrospective study has proven the effectiveness and tolerability of [...]
A study conducted by researchers at the Mannheim Medical Centre [...]
Renal medullary carcinoma is a very rare subtype of renal [...]
In this video, Dr W. Marston Linehan, chief of the [...]
Researchers in America have recently completed a study that analysed close [...]